Drugs / APC8020
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00616720 | Aug 2001 → Nov 2007 | plasma cell myeloma | Mayo Clinic | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | APC8020 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00616720 ↗ |
| Modality | Vaccine | “dendritic cell vaccine APC8020” NCT00616720 ↗ |
| Route | Intravenous | “idiotype-pulsed autologous dendritic cell vaccine APC8020 IV over 30-minutes on days 2, 16, and 30” NCT00616720 ↗ |